Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Eli Lilly priced FOUNDAYO comparably to the WEGOVY pill, with self-pay access starting at $149/month for the lowest dose, eligible commercial insurance patients paying as low as $25/month with savings cards, and Medicare Part D patients expected to access it for $50/month beginning July 1, 2026
In sum, the experts findings were that Defendants claims that its Products would provide fast relief for gas and bloating were neither clinically proven, nor were the Products capable of providing the promised results at the dosages Defendant recommends
Tirzepatides dual GIP/GLP-1 mechanism has demonstrated superior weight-loss efficacy in both clinical trials and real-world studies, enabling stronger payer uptake and prescriber preference
Oral supplements work well for daily support when absorption isn't critical
Protein shakes and body supplements act as a meal replacement
US$ 24.50
US$ 20.32
US$ 23.65
US$ 28.56
